Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-146b-5p


Loading... Please wait, this might take a few seconds...



Filters
Interactions: 579, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
CARD10 hsa-miR-146b-5p low: 2 high: 0 1 1 1 -
Low-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Colleen Cowan et al. 2014 WB qP Eye N/A N/A N/A
Location Method Result Regulation Validation Type Source
UNKNOWN Western Blot POSITIVE INDIRECT TarBase 7.0
UNKNOWN qPCR POSITIVE INDIRECT TarBase 7.0
NUP37 hsa-miR-146b-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:102073991-102074018 Chimeric fragments POSITIVE DIRECT TarBase 8.0
AP3S2 hsa-miR-146b-5p low: 0 high: 6 2 6 2 0.614
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr15:89835295-89835316 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:89835295-89835316 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:89835295-89835316 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:89835295-89835316 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:89835295-89835316 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:89835295-89835316 PAR-CLIP POSITIVE DIRECT TarBase 7.0
BTG2 hsa-miR-146b-5p low: 0 high: 6 4 6 4 0.663
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr1:203308470-203308490 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:203308470-203308490 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:203308470-203308490 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:203308470-203308490 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:203308470-203308490 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:203308470-203308490 PAR-CLIP POSITIVE DIRECT TarBase 7.0
KIAA1432 hsa-miR-146b-5p low: 0 high: 6 2 5 2 0.653
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr9:5774580-5774590 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:5774580-5774590 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:5774580-5774590 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:5774580-5774590 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:5775565-5775587 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr9:5774580-5774590 PAR-CLIP POSITIVE DIRECT TarBase 7.0
ITCH hsa-miR-146b-5p low: 0 high: 6 1 1 1 0.933
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr20:34509170-34509191 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr20:34509170-34509191 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr20:34509170-34509191 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr20:34509170-34509191 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr20:34509170-34509191 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr20:34509170-34509191 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF367 hsa-miR-146b-5p low: 0 high: 5 3 5 3 0.995
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr9:96387933-96387957 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr9:96387933-96387957 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:96387933-96387957 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:96387933-96387957 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:96387933-96387957 PAR-CLIP POSITIVE DIRECT TarBase 7.0
PTAR1 hsa-miR-146b-5p low: 0 high: 5 3 5 3 0.891
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr9:69714742-69714762 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:69714742-69714762 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:69714742-69714762 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr9:69714742-69714762 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr9:69714742-69714762 PAR-CLIP POSITIVE DIRECT TarBase 7.0
AP1G2 hsa-miR-146b-5p low: 0 high: 5 2 5 2 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr14:23560300-23560321 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr14:23560300-23560321 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr14:23560300-23560321 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr14:23560300-23560321 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr14:23560300-23560321 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RBL1 hsa-miR-146b-5p low: 0 high: 5 2 3 2 0.788
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:36997448-36997476 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:36997715-36997735 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr20:36997448-36997476 PAR-CLIP POSITIVE DIRECT TarBase 7.0
chr20:36996972-36996996 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:36997448-36997476 PAR-CLIP POSITIVE DIRECT TarBase 7.0
DYNLL2 hsa-miR-146b-5p low: 0 high: 5 1 1 1 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr17:58092250-58092269 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:58090087-58090106 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr17:58090087-58090106 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:58090087-58090106 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr17:58090087-58090106 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SPEN hsa-miR-146b-5p low: 0 high: 4 2 2 2 0.644
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr1:15934340-15934362 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:15939317-15939336 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:15939317-15939336 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:15939317-15939336 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PIGB hsa-miR-146b-5p low: 0 high: 4 2 4 2 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:55329782-55329802 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:55329782-55329802 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:55329782-55329802 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:55329782-55329802 PAR-CLIP POSITIVE DIRECT TarBase 7.0
COPA hsa-miR-146b-5p low: 0 high: 4 2 4 2 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr1:160289304-160289327 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:160289304-160289327 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:160289304-160289327 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:160289304-160289327 PAR-CLIP POSITIVE DIRECT TarBase 7.0
HNRNPA2B1 hsa-miR-146b-5p low: 0 high: 4 3 3 3 0.473
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland MDAMB231 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:26200675-26200697 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr7:26200675-26200697 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:26200675-26200697 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr7:26200675-26200697 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TP53INP1 hsa-miR-146b-5p low: 0 high: 4 3 3 3 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr8:94939963-94939986 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr8:94939963-94939986 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr8:94939963-94939986 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr8:94927649-94927671 PAR-CLIP POSITIVE DIRECT TarBase 7.0
C16orf72 hsa-miR-146b-5p low: 0 high: 4 2 4 2 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Bone Marrow C8166 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:9105099-9105119 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr16:9105099-9105119 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:9105099-9105119 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr16:9105099-9105119 PAR-CLIP POSITIVE DIRECT TarBase 7.0
MAP3K5 hsa-miR-146b-5p low: 0 high: 4 2 4 2 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:136558841-136558860 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:136558841-136558860 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:136558841-136558860 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:136558841-136558860 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SLC2A3 hsa-miR-146b-5p low: 0 high: 3 3 3 1 0.697
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Bone Marrow C8166 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:7919316-7919338 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:7919759-7919782 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr12:7919759-7919782 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLK hsa-miR-146b-5p low: 0 high: 3 2 3 2 0.631
High-throughput experiments (3 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr10:104027444-104027466 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr10:104027444-104027466 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr10:104027444-104027466 PAR-CLIP POSITIVE DIRECT TarBase 7.0